BURT A ADELMAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BURT A ADELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BURT A ADELMAN. BURT A ADELMAN is Executive VP Development in BIOGEN INC. ($IDPH) and Executive VP, Development in BIOGEN INC. ($IDPH) and CMO & EVP, R&D in DYAX CORP ($DYAX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB).
Latest Insider Trading Transactions of BURT A ADELMAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, CATB, DYAX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2020 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 6.17 | 7,500 | 46,275 | 7,500 | |
| Jun 05 2019 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 6.53 | 7,500 | 48,975 | 7,500 | |
| Jun 07 2018 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 1.48 | 14,000 | 20,720 | 14,000 | |
| Jul 28 2017 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 1.27 | 6,500 | 8,255 | 6,500 | |
| Apr 07 2016 | CATB | CATABASIS PHARMACE ... | ADELMAN BURT A | Director | Option Exercise | A | 4.80 | 13,000 | 62,400 | 13,000 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 15.23 | 500,000 | 7,615,000 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 10.20 | 225,000 | 2,295,000 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 4.33 | 235,000 | 1,017,550 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 3.00 | 233,749 | 701,247 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 2.29 | 68,542 | 156,961 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | D | 1.48 | 42,232 | 62,503 | 0 | |
| Jan 22 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Sell | D | 0.00 | 208,602 | 0 | 0 | 208.6 K to 0 (-100.00 %) |
| Jan 15 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | M | 3.00 | 1,251 | 3,753 | 233,749 | |
| Jan 15 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | M | 2.29 | 1,458 | 3,339 | 68,542 | |
| Jan 15 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | M | 1.48 | 140,268 | 207,597 | 42,232 | |
| Jan 15 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Buy | M | 3.00 | 1,251 | 3,753 | 208,602 | 207.4 K to 208.6 K (+0.60 %) |
| Jan 15 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Buy | M | 2.29 | 1,458 | 3,339 | 207,351 | 205.9 K to 207.4 K (+0.71 %) |
| Jan 15 2016 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Buy | M | 1.48 | 140,268 | 207,597 | 205,893 | 65.6 K to 205.9 K (+213.74 %) |
| Dec 22 2015 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | M | 1.48 | 10,000 | 14,800 | 182,500 | |
| Dec 22 2015 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Buy | M | 1.48 | 10,000 | 14,800 | 65,625 | 55.6 K to 65.6 K (+17.98 %) |
| Dec 18 2015 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Option Exercise | M | 1.48 | 27,500 | 40,700 | 192,500 | |
| Dec 18 2015 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Buy | M | 1.48 | 27,500 | 40,700 | 55,625 | 28.1 K to 55.6 K (+97.78 %) |
| Mar 06 2015 | DYAX | DYAX CORP | ADELMAN BURT A | CMO & EVP, R&D | Sell | S | 15.66 | 9,375 | 146,843 | 28,125 | 37.5 K to 28.1 K (-25.00 %) |
| Mar 31 2004 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP Develo ... | Option Exercise | M | 9.67 | 8,222 | 79,507 | 37,778 | |
| Mar 31 2004 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP Develo ... | Option Exercise | M | 7.31 | 4,370 | 31,945 | 0 | |
| Mar 31 2004 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP Develo ... | Sell | S | 53.37 | 8,222 | 438,808 | 12,269 | 20.5 K to 12.3 K (-40.12 %) |
| Mar 31 2004 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP Develo ... | Buy | M | 9.67 | 8,222 | 79,507 | 20,491 | 12.3 K to 20.5 K (+67.01 %) |
| Mar 31 2004 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP Develo ... | Sell | S | 53.37 | 4,370 | 233,227 | 12,269 | 16.6 K to 12.3 K (-26.26 %) |
| Mar 31 2004 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP Develo ... | Buy | M | 7.31 | 4,370 | 31,945 | 16,639 | 12.3 K to 16.6 K (+35.62 %) |
| Dec 08 2003 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP, Devel ... | Option Exercise | M | 7.31 | 8,625 | 63,049 | 4,370 | |
| Dec 08 2003 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP, Devel ... | Sell | S | 38.38 | 8,625 | 331,028 | 269 | 8.9 K to 269 (-96.98 %) |
| Dec 08 2003 | IDPH | BIOGEN INC. | ADELMAN BURT A | Executive VP, Devel ... | Buy | M | 7.31 | 8,625 | 63,049 | 8,894 | 269 to 8.9 K (+3,206.32 %) |
Page: 1